Johnson & Johnson is peeling off a consumer health business that helped it become the world’s biggest health care products maker. The company said Friday that it will separate its segment that sells Band-Aids, Listerine and over-the-counter medicines like Tylenol from its pharmaceutical and medical device business. Company leaders told analysts that the split into two publicly traded companies will make each business more nimble in adapting to their respective markets.